Edwards Lifesciences Corporation

Financials

Flujo de caja de las actividades operativas 1.05 B1.73 B1.22 B895.8 M542.3 M1.6 B 1.6 B Flujo de caja de las actividades de inversión -531.1 M-1.72 B252.3 M173.8 M2.31 B-712.9 M -712.9 M Flujo de caja de las actividades financieras -486.9 M-356.3 M-1.58 B-711 M-983 M-956.8 M -956.8 M Flujo de caja libre 647 M1.4 B953.4 M629.5 M259.9 M1.33 B 1.33 B

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland.

EW

Financials

Edwards Lifesciences Corporation

Noticias

Top Stock Reports for Eli Lilly, Mastercard & AMD

El CFO de Edwards Lifesciences, Ullem, vende acciones por 1 millón de dólares

I Shared 42 Sell Ratings In 2019. Here Is How They Have Performed Long-Term.

CVP de Edwards Lifesciences Lippis vende acciones por 82.522 dólares

Boston Scientific: From Hypergrowth To Durable Compounding (NYSE:BSX)

Edwards muestra menor mortalidad en datos de ensayo de válvula tricúspide

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?

Should You Continue to Hold Bio-Techne Stock in Your Portfolio?

Should You Continue to Hold Integra Stock in Your Portfolio Now?

Edwards Lifesciences: More Appeal For The Heart (NYSE:EW)

Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now

Edwards Lifesciences Stock Up 22.1% in a Year: What's Driving It?